The performance of transcatheter aortic valve replacement has expanded considerably
during the past decade. Technological advances and refinement in implantation techniques …

Background: It is unknown whether the direct oral anticoagulant edoxaban can reduce
leaflet thrombosis and the accompanying cerebral thromboembolic risk after transcatheter …

Background Subclinical leaflet thrombosis has been reported after bioprosthetic aortic valve
replacement, characterized using 4-dimensional computed tomographic imaging by …

OBJECTIVES We examined the incidence, the impact of subsequent cerebrovascular events
and the clinical or procedural predictors of leaflet thrombosis (LT) in patients undergoing …

Now in its sixth edition, Robert M. Bojar's Manual of Perioperative Care in Adult Cardiac
Surgery remains the go-to practical guide for all of those involved in the care of the cardiac …

Background: The optimal antithrombotic regimen after transcatheter aortic valve
replacement remains unclear. Methods: In this randomized open-label study, low-risk …

Background Previous studies demonstrated transcatheter aortic valve replacement (TAVR)
with an earlier generation balloon-expandable valve to be noninferior to surgical aortic valve …

Background Subclinical obstructive valve thrombosis after transcatheter aortic valve
replacement (TAVR) is of uncertain frequency and clinical impact. Objectives The aim of this …

Bioprosthetic valve thrombosis may complicate transcatheter aortic valve implantation
(TAVI). This meta-analysis sought to evaluate the prevalence and clinical impact of …

Background Subclinical leaflet thrombosis (SLT) is characterized on computed tomography
(CT) imaging as hypoattenuated leaflet thickening (HALT), reduced leaflet motion (RELM) …